To further investigate the differences in tumor-infiltrating immune cells (TIICs) between the GFPT1-Low and GFPT1-High groups, we applied the CIBERSORT algorithm to breast cancer patients from the TCGA cohort. This evidence concerns the gene GFPT1 and neoplasm.